Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ECHODIA is a French medical device company focused on hearing assessment, otorhinolaryngology, and neuroscience. The company develops, manufactures, and markets non-invasive diagnostic and screening devices for auditory measurements used by ENT physicians, hospitals, neonatology teams, occupational health services, school health services, and hearing-care professionals. Its product portfolio includes audiometers, otoacoustic emission and auditory evoked potential systems, neonatal hearing screening tools, and proprietary tests intended to detect endolymphatic hydrops associated with Ménière’s disease. ECHODIA emphasizes made-in-France manufacturing, ISO 13485-certified design and production, and accompanying software for device control, patient data management, and reporting. The company appears to be a commercial-stage medtech business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ECHODIA.